Roche leads the clinical development of Evrysdi as part of a collaboration with the SMA Foundation and PTC Therapeutics... Apr 17
PTC518 is a small molecule splicing modifier that acts via a unique mechanism to promote the inclusion of a novel pseudoexon ... Nov 19
Another drug in development for treatment of Coronavirus patients... Jun 23
-Advertisements-